Skip to main content

Early Single-Examination Optical Coherence Tomography Biomarkers for Treatment-Requiring Retinopathy of Prematurity.

Publication ,  Journal Article
Chen, X; Mangalesh, S; He, J; Winter, KP; Tai, V; Toth, CA; Ying, G-S
Published in: Invest Ophthalmol Vis Sci
April 1, 2024

PURPOSE: Optical coherence tomography (OCT) is an emerging adjunct imaging modality to evaluate retinopathy of prematurity (ROP). From an 11-year research database, we identify early OCT biomarkers that predict treatment-requiring ROP (TR-ROP). METHODS: For preterm infants with acceptable OCT images at 32 ± 1 weeks postmenstrual age (PMA), we extracted the following measures: total retina, inner retinal layer (IRL), and outer retinal layer (ORL) thicknesses at the fovea and the parafovea, inner nuclear layer (INL) and choroidal thickness, parafovea/fovea (P/F) ratio, and presence of macular edema. Using univariable and multivariable logistic regression models, we evaluated the association between retinal and choroidal OCT measurements at 32 ± 1 weeks PMA and development of TR-ROP. RESULTS: Of 277 eyes (145 infants) with usable OCT images, 67 eyes had TR-ROP. Lower P/F ratio (P < 0.0001), thicker foveal IRL (P = 0.0001), and thinner choroid (P = 0.03) were associated with TR-ROP in univariable analysis, but lost significance of association when adjusted for gestational age and race. Absence of macular edema was associated with TR-ROP when adjusted for gestational age and race (P = 0.01). In 185 eyes without macular edema, P/F ratio was associated with TR-ROP in both univariable analysis (P < 0.0001) and multivariable analysis (P = 0.02) with adjustment for gestational age and race. CONCLUSIONS: Presence of macular edema at 32 ± 1 weeks PMA in infants with lower gestational age may be protective against TR-ROP. In infants without macular edema, P/F ratio may be an early OCT biomarker for development of TR-ROP. Incorporation of early OCT biomarkers may be useful in prediction of TR-ROP.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Invest Ophthalmol Vis Sci

DOI

EISSN

1552-5783

Publication Date

April 1, 2024

Volume

65

Issue

4

Start / End Page

21

Location

United States

Related Subject Headings

  • Tomography, Optical Coherence
  • Retinopathy of Prematurity
  • Retina
  • Ophthalmology & Optometry
  • Macular Edema
  • Infant, Premature
  • Infant, Newborn
  • Infant
  • Humans
  • Biomarkers
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chen, X., Mangalesh, S., He, J., Winter, K. P., Tai, V., Toth, C. A., & Ying, G.-S. (2024). Early Single-Examination Optical Coherence Tomography Biomarkers for Treatment-Requiring Retinopathy of Prematurity. Invest Ophthalmol Vis Sci, 65(4), 21. https://doi.org/10.1167/iovs.65.4.21
Chen, Xi, Shwetha Mangalesh, Jocelyn He, Katrina P. Winter, Vincent Tai, Cynthia A. Toth, and Gui-Shuang Ying. “Early Single-Examination Optical Coherence Tomography Biomarkers for Treatment-Requiring Retinopathy of Prematurity.Invest Ophthalmol Vis Sci 65, no. 4 (April 1, 2024): 21. https://doi.org/10.1167/iovs.65.4.21.
Chen X, Mangalesh S, He J, Winter KP, Tai V, Toth CA, et al. Early Single-Examination Optical Coherence Tomography Biomarkers for Treatment-Requiring Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):21.
Chen, Xi, et al. “Early Single-Examination Optical Coherence Tomography Biomarkers for Treatment-Requiring Retinopathy of Prematurity.Invest Ophthalmol Vis Sci, vol. 65, no. 4, Apr. 2024, p. 21. Pubmed, doi:10.1167/iovs.65.4.21.
Chen X, Mangalesh S, He J, Winter KP, Tai V, Toth CA, Ying G-S. Early Single-Examination Optical Coherence Tomography Biomarkers for Treatment-Requiring Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):21.

Published In

Invest Ophthalmol Vis Sci

DOI

EISSN

1552-5783

Publication Date

April 1, 2024

Volume

65

Issue

4

Start / End Page

21

Location

United States

Related Subject Headings

  • Tomography, Optical Coherence
  • Retinopathy of Prematurity
  • Retina
  • Ophthalmology & Optometry
  • Macular Edema
  • Infant, Premature
  • Infant, Newborn
  • Infant
  • Humans
  • Biomarkers